Seeking Alpha

Justin M. Hall's  Instablog

Justin M. Hall is an entrepreneur, investor and author. Hall serves as owner and founder of HiRx, LLC located in Indianapolis, Indiana. He is the author of "The Option Investors Desk Reference©" (2008). Hall invests in areas of innovative growth, such as (1) late-stage drug, device... More
My blog:
SeekingAlpha Instablog
  • Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Look 2 comments
    Jul 29, 2009 09:08 AM | about stocks: ARIA, SPPI, ONTY, GTXI, ONB, PRXL, OSIR, UNG, TOMO, CLNE, SUPG, FSYS, SWC
     
    Ariad Pharmaceuticals (Nasdaq: ARIA): Advancing in Front of Phase 3 Interim Look
     
    The Lucky 13 Buys portfolio continues to advance. 
     
    In the past two sessions, some of the companies have seen a dramatic rise in their share prices. View the results from Friday, July 24 in this article.
     
    As of the close on Tuesday, July 28, four companies are up over 30%. While seven of the 13 have achieved gains exceeding 20%, nine are above 10%.
     

    Symbol
    Last/NAV
    %Gain/Loss
    ARIA
    2.80
    85.43%
    ONTY
    4.40
    37.07%
    SUPG
    2.70
    33.00%
    GTXI
    10.58
    30.46%
    FSYS
    23.98
    28.79%
    SWC
    6.39
    26.04%
    ONB
    11.33
    20.92%
    SPPI
    6.75
    19.89%
    PRXL
    14.44
    14.33%
    UNG
    12.90
    5.91%
    TOMO
    2.78
    5.30%
    CLNE
    8.94
    3.83%
    OSIR
    12.70
    1.36%

     
    Data is based on the closing prices on Tuesday July 7 to Tuesday July 27, 2009.
     
     
    Ariad Pharmaceuticals (Nasdaq: ARIA) shares jumped following a significant Phase 1 clinical trial announcement and in front of much anticipated interim phase 3 results for the company’s cancer drug, ridaforolimus. An announcement is due any day. ARIA will report quarterly earnings on Thursday, July 30 at 4:15 PM ET. Investors can access the webcast here.
     
    Spectrum Pharmaceuticals (Nasdaq: SPPI) continues its climb as investors anticipate the company’s two cancer drugs, Zevalin and Fusilev, will be approved on or before September 7 and October 8, 2009, respectively.
     
    Old National Bank (NYSE: ONB) rose early this week on a positive quarterly earnings announcement.
     
     
    Disclosure: Long ARIA and SPPI
    Themes: biotech, drug makers, small cap Stocks: ARIA, SPPI, ONTY, GTXI, ONB, PRXL, OSIR, UNG, TOMO, CLNE, SUPG, FSYS, SWC
Back To Justin M. Hall's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

This post has 2 comments:

  •  
    JUSTIN is it possible that the large sell off in ARIA was a short against the 10.8 ml options at 2.15 that can be exercise from 8.25.2009?
    Jul 30 10:47 AM | Link | Reply
  •  
    HEGE:

    Thank you for the question.

    While it's certainly possible, I would not worry about the day to day action. Anything is always possible. I try to stay focused on the bigger picture, and from my view ARIA has a great deal of potential.

    Good luck.

    Justin


    On Jul 30 10:47 AM HEGE wrote:

    Is it possible that the large sell off in ARIA was a short against the 10.8 ml options at 2.15 that can be exercise from 8.25.2009?
    Jul 31 02:39 AM | Link | Reply
Full index of posts »
Latest Followers
Posts by Ticker

Latest Comments


Most Commented
  1. Update: 10.9.09 (46 Comments)
  2. FULL DISCLOSURE STATEMENT (18 Comments)
  3. Spectrum Pharmaceuticals: Undervalued and [now] Oversold (17 Comments)
  4. Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern (15 Comments)
  5. A NECESSARY COMPROMISE (14 Comments)
Posts by Themes
Are You Paying Attention, Are You Paying Attention , ASH 2009, biotech, Biotech, Biotech , Biotech Diagnosis, Biotech Equipment, Biotech Research, biotechnology, Cancer Drugs, Charlie Heidenreich, Charlie Heidenreich’s first article, China, Clean Energy, Commodity ETFs, Currency ETFs, DJ HERO, Drug Makers, drug makers, Drug Manufacturers, Drug Manufacturers , Emerging Markets, ETF, ETFs, FULL DISCLOSURE STATEMENT, Gold, Health Plans, Healthcare, Hospitals/Care Facilities, Industrials, Intelius, Long Ideas, Lucky 13 Buys, Lucky 13 Buys 2.0, Lucky 13 Buys 2.0 , Medical Equipment, Mergers Acquisitions, Mining, More Potential Buys List, N-95 Respirator Masks, Natural Gas, Options, Pharmaceutical, pharmaceutical, pharmaceuticals, Precious Metals, Regional Banks, Results, Short Ideas,
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.